See the AI products entering care.

One organization-deployed platform spanning preparation, documentation and follow-through; clinician review remains required.

Generally available ambient documentation product; do not merge with the planned Sunrise Pulse AI companion.

Enterprise suite spanning chart summaries, scribing, orders and patient instructions; clinician review and audit remain explicit.

Count the configurable platform once; its digital-front-door, virtual-hospital, monitoring, collaboration and transition agents are capabilities, not five products.

Count one clinical-operations platform. Fax Genie is live; Pathway Genie remains a pilot and is not a second record.

Native and partner-model ambient documentation plus chart insights; do not treat every model choice as a separate product.

Cancer-risk and referral decision support used by clinicians; count one platform and retain country-specific availability and intended-use caveats.

Institution-specific clinical AI scientist; it is not a public self-service product.

Commure says Ambient AI replatforms and enhances Augmedix, whose Go, Assist and Live pages remain active; treat them as one current family, not a second record. The family includes AI-only and human-supported tiers, so do not attribute human-service outcomes to AI alone. Commure reports a Class I CE mark, MHRA registration and UK/EU commercial availability; buyers must verify the exact certificate, registration and country scope. Clinicians review and sign notes before they enter the patient record.

Specialty and enterprise documentation platform; clinician reviews the note.

Self-service clinician assistant; outputs remain support rather than final clinical authority.

One suite covering Ask, Scribe and Dialer for verified clinicians; each output remains clinician-reviewed.

AI pre-fills pharmacy and medical coverage requests from prescribing information for clinicians or staff to review and submit. Offered within DrFirst prescribing, with a continuing EHR rollout and an iPrescribe route for independent practices. It does not determine coverage or replace clinical judgment.

Retrieves and summarizes external records; source completeness and clinician review remain important.

Ambient documentation product integrated with multiple EHRs; it is distinct from PRISMA and healow Genie.

Chart-grounded insights in the EHR; it does not establish autonomous clinical authority.

Individual trial and institutional access vary by market; answers are grounded in licensed content.

Epic-supplied clinician AI across documentation, chart insights and messages. Memorial Hermann reports expanded use after a December 2025 pilot: Art drafts lab and imaging result comments in Epic In Basket for clinicians to review, edit and personalize before sharing. Features depend on each health system's release and configuration. Reported message and time savings are customer-reported operational results, not independent clinical outcomes; the report does not provide evaluation dates or a full comparator denominator.

Enterprise chart intelligence and clinician chat; deployment evidence does not prove clinical outcomes.

Organization-deployed modular platform spanning patient engagement, AI call center, referrals and care management; not a consumer assistant.

AI-supported referral intake, triage and follow-through for access teams; patient communications are capabilities, not a separate patient product.

Freed AI Scribe contains documentation and tier-dependent clinical evidence, coding and patient-letter tools. The separately priced Freed Front Desk offer is outside this record. Clinicians review generated content. Pricing says audio is deleted after summaries and quality checks, while help documentation describes a 28-day Resume window and a 14-day limit for paused visits. Retention varies by workflow and is not fully reconciled across public sources; confirm the applicable settings before recording.

Distinct clinician product; do not merge with Glass for Patients.

Distinct EHR-embedded chart insight, coding and documentation suite; clinician approval remains required.

One suite covering notes, letters, codes and evidence; licensed clinician retains responsibility.

Produces separate clinician and patient summaries; early adoption and outcome claims need independent verification.

Assistant within HealthShare Unified Care Record from version 2025.2, distinct from IntelliCare. Access depends on the customer's license and configuration; external AI runtime and data-use terms apply. Clinicians must verify summaries; exact country and model availability are not publicly confirmed.

Assistant embedded in IntelliCare for chart queries, summaries and proposed clinical actions; clinicians must approve diagnoses, orders and chart changes. InterSystems reported EU MDR certification in May 2026, superseding the brochure's earlier EU-pending note. Exact country, feature and UK availability remain unconfirmed; certification does not establish every AI feature's entitlement.

One clinician suite includes Florence, patient reports and a member app. Clinicians can start a paid-plan trial directly; larger organizations have enterprise access. It organizes patient data and drafts information for clinician review. Despite clinical marketing, current terms limit outputs to informational wellness use, not diagnosis or treatment; physician advice is required before action. Its FAQ and older terms conflict on encryption; applicable data-handling terms require confirmation. Regulatory clearance, exact genetic-test access and independent outcomes: Not publicly confirmed.

Conversational evidence support for registered clinicians; citations and clinician judgment remain necessary.

AI documentation feature within Medscape, distinct from Medscape's evidence-answering products. Current help lists registered US MDs on Android and US MDs, nurses, PAs and students on iOS. Clinicians must check and edit summaries before use; current detailed retention and contractual terms were not confirmed.

Assistant inside the MedThread practice and long-term-care platform; performance and partner-logo claims remain provider claims.

Functions and availability depend on deployment; draft outputs require clinician review and patient consent where applicable.

Specialty-specific documentation support; provider usage claims are not independent outcome evidence.

Web, mobile, extension and organization routes belong to one product. Authorized professionals must review and validate AI outputs before clinical use; the output is suggestive and may be inaccurate. Appropriate patient permissions and applicable data-processing or BAA terms are required. Nabla does not replace clinical judgment.

Documentation and workflow assistance within NextGen; clinician oversight remains required.

EHR workflow agent; institutional configuration and permissions determine what it can read or do.

Obesity and chronic-care platform with AI clinical decision support; no independent outcomes or distinct conversational assistant are proven.

Behavioral-health EHR with AI support for notes, treatment-plan drafts and diagnosis suggestions; outcome figures are provider claims.

Self-service workspace for eligible verified U.S. clinicians. Users can install the separate nine-source Healthcare Public Data plugin and connect available read-only apps individually; Epic remains unavailable to individual accounts. Public-source searches must not include PHI, and a BAA does not by itself authorize each external service. The product supports evidence work but does not replace clinician judgment.

Organization-deployed workspace with a read-only Epic plugin for approved deployments and a separate nine-source Healthcare Public Data plugin. Epic requires organization setup, each user's Epic sign-in and existing chart permissions; it cannot update records, place orders or message patients. Public-data apps are controlled separately and must not receive PHI; a BAA does not authorize each external service. Clinicians must review outputs, and organizations must confirm audit and export coverage.

One OpenEvidence product with selectable models: provider-stated production modes Osler (default and fast), Sackett (deeper evidence review) and Snow (successor to Deep Consult) began rolling out free to verified clinicians on web and iOS/Android on September 3. Darwin remains an application-only research preview for institutional partners and accredited researchers. The benchmark results are OpenEvidence-run and do not establish independent clinical effectiveness, specialty performance or patient outcomes. Clinicians retain judgment; rollout completion for every account is not independently confirmed.

Embedded in Oracle Health; clinicians review, confirm and sign outputs.

Emergency-medicine documentation suite for ambient notes and medical decision-making documentation, with clinical reasoning and reference support inside the workflow. Clinicians review and own the final chart and care decisions. The separately offered palmEM AI reference app is not merged into this suite record.

Inpatient chart-reading and diagnostic support; clinicians retain diagnosis and documentation authority.

Rhazes Clinician is the standalone, non-enterprise version for individual clinicians. Organization-wide EHR integration, configuration, batch auditing and third-party tools shown elsewhere on the site are not established as included in every individual account. Clinical outputs require professional judgment; validation and accuracy claims remain provider claims until independently scoped.

Organization and EHR-delivered assistant; availability depends on customer configuration.

Documentation application deployed on the Tandem platform; count Note Buddy as the end-user product, not Tandem as a second assistant.

Geography and medical-device status are market specific; clinician approves outputs.

The clinician reviews and signs the generated note and any proposed prescription workflow.

NHS-facing ambient assistant; product and regulatory claims apply to the documented UK scope.

AI image analysis is offered within VisualDx subscriptions. The FAQ describes an add-on, while current plan summaries also list AI skin analysis; exact inclusion depends on the account. Current FAQs require a mobile device, but a 2023 product update offered DermExpert web access to ecommerce users; current web entitlement is Not publicly confirmed. Clinicians review lesion suggestions and the differential; the tool does not replace diagnosis or independent judgment. Exact regional eligibility is Not publicly confirmed.

AI experience within UpToDate personal or institutional access, with eligibility varying by region and subscription. Wolters Kluwer names Mandaya Royal Hospital Puri in Indonesia as an implementing hospital. This provider-hosted account supports a named deployment, not independently measured clinical outcomes; clinicians retain diagnosis and treatment decisions.

Organization-deployed record-processing and source-linked clinical-summary product; xCures states it is not a direct-to-patient service.